CD274 and cancer: They showed that RESV disrupted N-glycan branching and promoted PD-L1 dimerization, thereby impeding the correct localization of PD-L1 to the plasma membrane and preventing the surface interaction of PD-L1 with PD-1, and as a consequence, the compound increased the susceptibility of cancer cells to T cell-mediated cell death [78].